Context Therapeutics Inc (CNTX)

Precedente Chiudi:

$1.85

Aprire:

$1.82

Volume 24 ore:

206.93K

Capitalizzazione di mercato:

$28.42M

Reddito:

-

Utile/perdita netta:

$-23.96M

Rapporto P/E:

-1.5215

EPS:

-1.17

Flusso di cassa netto:

$-21.05M

1 W Prestazione:

+29.93%

1M Prestazione:

+40.17%

6M Prestazione:

+44.72%

1 anno Prestazione:

+223.71%

Intervallo 1D:

$1.70

$1.83

Portata 52W:

$0.47

$1.88

Context Therapeutics Inc Stock (CNTX) Company Profile

Nome

Context Therapeutics Inc

Settore

Healthcare (1223)

Industria

Biotechnology (699)

Telefono

267 225 7416

Indirizzo

2001 Market Street, Suite 3915 Unit #15, Philadelphia

Dipendente

0

Cinguettio

Prossima data di guadagno

Ultimi documenti SEC

CNTX's Discussions on Twitter

Context Therapeutics Inc Borsa (CNTX) Ultime notizie

Context Therapeutics Announces FDA Clearance of IND Application for a Phase 1 Clinical Trial of CTIM-76

GlobeNewswire Inc.

Context Therapeutics Submits IND Application to Evaluate CTIM-76 in Claudin 6-Positive Cancers

GlobeNewswire Inc.

Context Therapeutics Reports Full Year 2023 Operating and Financial Results

GlobeNewswire Inc.

Why Quanex Building Products Shares Are Trading Lower By Over 10%? Here Are Other Stocks Moving In Friday's Mid-Day Session

Benzinga

Constellation Energy, Battalion Oil And Other Big Stocks Moving Higher On Friday

Benzinga

Context Therapeutics Reports Third Quarter 2023 Operating and Financial Results

GlobeNewswire Inc.

Context Therapeutics Inc Azioni (CNTX) Dati Finanziari

Context Therapeutics Inc (CNTX) Reddito netto 2024

Context Therapeutics Inc (CNTX) Flusso di cassa 2024

Context Therapeutics Inc (CNTX) Utile per azione 2024